iShares Genomics Immunology and Healthcare ETF
Open-end / ETFRegistrant
iShares Trust
Class ticker
Net Assets
$190,862,668
Holdings
61
Latest Report
Jul 31, 2026
Net Assets Over Time
Holdings · 61
Export CSVSecurities-lending collateral: 1 row, $19,834,626 (10.39% of net assets). The report marks these as cash received from borrowers of the fund's securities and reinvested, not as positions the fund chose.
Showing 1–50
of 61 holdings by value
· page 1 of 2
| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
|
BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares
Lending collateral
|
066922519 | 19,834,626 | $19,834,626 | 10.39% | Long | STIV | |
|
Bayer Aktiengesellschaft
|
— | 165,508 | $9,184,987 | 4.81% | Long | EC | |
| Twist Bioscience Corp | TWST | 99,937 | $9,149,232 | 4.79% | Long | EC | |
| REVOLUTION MEDICINES, INC. | RVMD | 46,352 | $8,692,391 | 4.55% | Long | EC | |
| REGENERON PHARMACEUTICALS, INC. | REGN | 10,887 | $8,302,753 | 4.35% | Long | EC | |
|
GENMAB A/S
|
— | 28,069 | $8,079,336 | 4.23% | Long | EC | |
| INCYTE CORPORATION | INCY | 67,570 | $8,075,966 | 4.23% | Long | EC | |
| MODERNA, INC. | MRNA | 145,819 | $7,993,798 | 4.19% | Long | EC | |
|
Takeda Pharmaceutical Company Limited
|
— | 225,100 | $7,728,949 | 4.05% | Long | EC | |
| MERCK & CO., INC. | MRK | 57,270 | $7,456,554 | 3.91% | Long | EC | |
| VERTEX PHARMACEUTICALS INCORPORATED | VRTX | 15,481 | $7,385,985 | 3.87% | Long | EC | |
|
Roche Holding AG
|
— | 16,796 | $7,341,404 | 3.85% | Long | EC | |
|
IPSEN SA
|
— | 37,928 | $7,328,654 | 3.84% | Long | EC | |
| BioNTech SE | BNTX | 78,540 | $7,114,153 | 3.73% | Long | — | |
| EXELIXIS, INC. | EXEL | 131,275 | $6,961,513 | 3.65% | Long | EC | |
|
GSK PLC
|
— | 266,670 | $6,934,182 | 3.63% | Long | EC | |
|
SANOFI SA
|
— | 76,788 | $6,612,342 | 3.46% | Long | EC | |
| IDEAYA Biosciences Inc | IDYA | 180,483 | $6,407,147 | 3.36% | Long | EC | |
| Immunitybio Inc | IBRX | 817,183 | $5,859,202 | 3.07% | Long | EC | |
| ARCUS BIOSCIENCES, INC. | RCUS | 181,763 | $5,123,899 | 2.68% | Long | EC | |
| CARIS LIFE SCIENCES, INC. | CAI | 266,135 | $4,170,335 | 2.18% | Long | EC | |
|
ONO PHARMACEUTICAL CO., LTD.
|
— | 244,500 | $3,654,051 | 1.91% | Long | EC | |
| Iovance Biotherapeutics Inc | IOVA | 841,830 | $3,426,248 | 1.80% | Long | EC | |
| NUVATION BIO INC. | NUVB | 536,281 | $3,394,659 | 1.78% | Long | EC | |
| CRISPR Therapeutics AG | CRSP | 62,247 | $2,987,234 | 1.57% | Long | EC | |
| ABCELLERA BIOLOGICS INC. | ABCL | 508,935 | $2,906,019 | 1.52% | Long | EC | |
| Vir Biotechnology Inc | VIR | 289,265 | $2,505,035 | 1.31% | Long | EC | |
| NOVAVAX, INC. | NVAX | 339,643 | $2,486,187 | 1.30% | Long | EC | |
| Janux Therapeutics Inc | JANX | 124,166 | $1,883,598 | 0.99% | Long | EC | |
|
Sunshine Lake Pharma Co Ltd
|
Y8243F109 | 351,500 | $1,874,392 | 0.98% | Long | EC | |
| Corvus Pharmaceuticals Inc | CRVS | 137,099 | $1,817,933 | 0.95% | Long | EC | |
| Personalis Inc | PSNL | 134,479 | $1,702,504 | 0.89% | Long | EC | |
| Kura Oncology Inc | KURA | 186,448 | $1,679,896 | 0.88% | Long | EC | |
|
GenFleet Therapeutics (Shanghai) Inc
|
Y2S2YD109 | 419,200 | $1,480,868 | 0.78% | Long | EC | |
| RIGEL PHARMACEUTICALS, INC. | RIGL | 38,807 | $1,428,486 | 0.75% | Long | EC | |
| CytomX Therapeutics Inc | CTMX | 375,908 | $1,165,315 | 0.61% | Long | EC | |
| VERASTEM, INC. | VSTM | 178,719 | $1,036,570 | 0.54% | Long | EC | |
| Alvotech SA | ALVO | 244,900 | $1,008,988 | 0.53% | Long | EC | |
| Design Therapeutics Inc | DSGN | 81,808 | $996,421 | 0.52% | Long | EC | |
| Xencor Inc | XNCR | 48,671 | $983,641 | 0.52% | Long | EC | |
| INTELLIA THERAPEUTICS, INC. | NTLA | 91,888 | $981,364 | 0.51% | Long | EC | |
|
Shanghai Henlius Biotech Inc
|
— | 135,900 | $964,127 | 0.51% | Long | EC | |
| OCUGEN, INC. | OCGN | 723,783 | $890,253 | 0.47% | Long | EC | |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | PACB | 622,048 | $870,867 | 0.46% | Long | EC | |
|
VALNEVA SE
|
— | 349,239 | $866,333 | 0.45% | Long | EC | |
| Ginkgo Bioworks Holdings Inc | DNA | 101,324 | $819,711 | 0.43% | Long | EC | |
|
AbClon Inc.
|
Y0R0KQ104 | 34,319 | $469,839 | 0.25% | Long | EC | |
| Prime Medicine, Inc | PRME | 65,480 | $191,202 | 0.10% | Long | EC | |
|
BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares
|
066922477 | 177,863 | $177,863 | 0.09% | Long | STIV | |
|
JAPANESE YEN
|
— | 11,386,897 | $71,568 | 0.04% | — | — |
Showing the top 50 of 61 holdings. Create a free account to see every holding and download the CSV.